TY  - JOUR
AU  - Blanco, Gonzalo
AU  - Puiggros, Anna
AU  - Baliakas, Panagiotis
AU  - Athanasiadou, Anastasia
AU  - Garcia-Malo, MaDolores
AU  - Collado, Rosa
AU  - Xochelli, Aliki
AU  - Rodriguez-Rivera, Maria
AU  - Ortega, Margarita
AU  - Jose Calasanz, Ma
AU  - Luno, Elisa
AU  - Vargas, MaTeresa
AU  - Grau, Javier
AU  - Martinez-Laperche, Carolina
AU  - Valiente, Alberto
AU  - Cervera, Jose
AU  - Anagnostopoulos, Achilles
AU  - Gimeno, Eva
AU  - Abella, Eugenia
AU  - Stalika, Evangelia
AU  - Ma Hernandez-Rivas, Jesus
AU  - Jose Ortuno, Francisco
AU  - Robles, Diego
AU  - Ferrer, Ana
AU  - Ivars, David
AU  - Gonzalez, Marcos
AU  - Bosch, Francesc
AU  - Abrisqueta, Pau
AU  - Stamatopoulos, Kostas
AU  - Espinet, Blanca
PY  - 2016
DO  - 10.18632/oncotarget.13106
UR  - http://hdl.handle.net/10668/19441
T2  - Oncotarget
AB  - Patients with chronic lymphocytic leukemia (CLL) harboring TP53 aberrations (TP53abs; chromosome 17p deletion and/or TP53 mutation) exhibit an unfavorable clinical outcome. Chromosome 8 abnormalities, namely losses of 8p (8p-) and gains of 8q (8q+)...
LA  - en
PB  - Impact journals llc
KW  - 17p deletion
KW  - Cll
KW  - Mutations
KW  - Cytogenetics
KW  - Progression
KW  - Guidelines
KW  - Diagnosis
KW  - Predicts
KW  - Genes
KW  - Fish
TI  - Karyotypic complexity rather than chromosome 8 abnormalities aggravates the outcome of chronic lymphocytic leukemia patients with TP53 aberrations
TY  - research article
VL  - 7
ER  -